BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Limosilactobacillus reuteri {L. Reuteri} - Blautia |
👶
<i>Lactobacillus reuteri</i> DSM 17938 feeding of healthy newborn mice regulates immune responses while modulating gut microbiota and boosting beneficial metabolites. American journal of physiology. Gastrointestinal and liver physiology (Am J Physiol Gastrointest Liver Physiol ) Vol: Issue Pages: Pub: 2019 Sep 4 Epub: 2019 Sep 4 Authors Liu Y , Tian X , He B , Hoang TK , Taylor CM , Blanchard E , Freeborn J , Park S , Luo M , Couturier J , Tran DQ , Roos S , Wu G , Rhoads JM , Html Article Publication |
| Limosilactobacillus reuteri {L. Reuteri} - Blautia |
📓
Lactobacillus reuteri improves the development and maturation of fecal microbiota in piglets through mother-to-infant microbe and metabolite vertical transmission. Microbiome (Microbiome ) Vol: 10 Issue 1 Pages: 211 Pub: 2022 Dec 2 Epub: 2022 Dec 2 Authors Wang G , Wang X , Ma Y , Cai S , Yang L , Fan Y , Zeng X , Qiao S , Html Article Publication |
| Limosilactobacillus reuteri {L. Reuteri} - Blautia |
📓
Lactobacillus reuteri mitigates hepatic ischemia/reperfusion injury by modulating gut microbiota and metabolism through the Nrf2/HO-1 signaling. Biology direct (Biol Direct ) Vol: 19 Issue 1 Pages: 23 Pub: 2024 Mar 18 Epub: 2024 Mar 18 Authors Zhang L , Gong X , Tan J , Zhang R , Li M , Liu C , Wu C , Li X , Html Article Publication |
| Limosilactobacillus reuteri {L. Reuteri} - Blautia |
📓
Synergistic activity of Limosilactobacillus reuteri KUB-AC5 and water-based plants against Salmonella challenge in a human in vitro gut model. Scientific reports (Sci Rep ) Vol: 14 Issue 1 Pages: 4730 Pub: 2024 Feb 27 Epub: 2024 Feb 27 Authors Mok K , Honwichit O , Funnuam T , Charoensiddhi S , Nitisinprasert S , Nielsen DS , Nakphaichit M , Html Article Publication |
| Limosilactobacillus reuteri {L. Reuteri} - Blautia |
📓
Lactobacillus reuteri strain 8008 attenuated the aggravation of depressive-like behavior induced by CUMS in high-fat diet-fed mice through regulating the gut microbiota. Frontiers in pharmacology (Front Pharmacol ) Vol: 14 Issue Pages: 1149185 Pub: 2023 Epub: 2023 Mar 27 Authors Li C , Su Z , Chen Z , Cao J , Liu X , Xu F , Html Article Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
